For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
How does the forecasted CAGR of the rotavirus vaccine industry compare to other sectors?
The rotavirus vaccine market size has grown rapidly in recent years. It will grow from $9.18 billion in 2024 to $10.14 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased awareness of rotavirus, improved healthcare infrastructure, government immunization programs, rising incidence of rotavirus infections, rising birth rates.
The rotavirus vaccine market size is expected to see rapid growth in the next few years. It will grow to $14.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to rising birth rates, the expansion of vaccination programs, an increased focus on preventive healthcare, economic growth and improved access, and government policies and funding. Major trends in the forecast period include advancements in vaccine technology, advancements in oral-dosing technologies, improved vaccine formulations, combination vaccines, and digital health integration.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp
What market trends are acting as primary growth drivers for the rotavirus vaccine sector?
The rising birth rates are expected to propel the growth of the rotavirus vaccine market going forward. Birth rates refer to the number of live births per 1,000 people in a population over a specific period, typically expressed annually. Birth rates are influenced by higher economic stability and growth, as well as supportive policies such as parental leave, child benefits, and childcare subsidies. The use of rotavirus vaccines helps to reduce the incidence of severe rotavirus gastroenteritis in infants, thereby improving child health outcomes and reducing healthcare costs associated with rotavirus infections. For instance, in January 2023, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health organization, the United States witnessed a 1% increase in registered births, totaling 3,664,292, compared to the previous year. Therefore, rising birth rates will drive the growth of the rotavirus vaccine market.
What are the fastest-growing segments in the rotavirus vaccine market forecast period?
The rotavirus vaccine market covered in this report is segmented –
1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research
Subsegments:
1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report
How are emerging trends transforming the rotavirus vaccine market dynamics?
Major companies operating in the rotavirus vaccine market are adopting oral-dosing applicators to enhance vaccine delivery efficiency and improve patient compliance. Oral-dosing applicators are medical devices designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and ease of use, especially for infants and young children. For instance, in November 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, received U.S. Food and Drug Administration (FDA) approval for a new oral-dosing applicator-only formulation of ROTARIX (Rotavirus Vaccine, Live, Oral). This liquid formulation prevents rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in infants. The new presentation simplifies vaccine preparation for healthcare providers by eliminating the need for dose reconstitution at the point of use.
Which major players hold significant market share in the rotavirus vaccine sector?
Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd., SK Chemicals Co Ltd., Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd
Which regional segments are forecasted to witness the fastest growth in the rotavirus vaccine market?
North America was the largest region in the rotavirus vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Rotavirus Vaccine Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20617
Need Customized Data On Rotavirus Vaccine Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20617&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
